Skip to main content
. 2018 Sep 14;104(5):940–948. doi: 10.1002/cpt.1180

Figure 3.

Figure 3

Enrollment by race in the drug targeting specific epidermal growth factor receptor mutations approved between 2008 and 2013. Includes subject level data from phase I–III trials for non‐small cell lung cancer (NSCLC) drugs approved between 2008 and 2013. AI‐AN, American Indian or Alaska Native; UNK‐NR, unknown/not reported.